Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic (Q28241661)

From Wikidata

Jump to navigation Jump to search

scientific article (publication date: August 2014)

Language	Label	Description	Also known as
English	Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic	scientific article (publication date: August 2014)

Statements

scholarly article

0 references

Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic (English)

0 references

0 references

Lorenzo Morelli

object named as

Lorenzo Morelli

7

0 references

Roberto Berni Canani

object named as

Roberto Berni Canani

8

0 references

Francisco Guarner

object named as

Francisco Guarner

2

0 references

object named as

Colin Hill

1

0 references

object named as

Philip C Calder

11

0 references

3

object named as

Gregor Reid

0 references

10

object named as

Seppo Salminen

0 references

author name string

Glenn R Gibson

4

0 references

Daniel J Merenstein

5

0 references

Bruno Pot

6

0 references

Harry J Flint

9

0 references

Mary Ellen Sanders

12

0 references

language of work or name

0 references

publication date

August 2014

0 references

Nature Reviews Gastroenterology & Hepatology

0 references

11

0 references

506-14

0 references

8

0 references

copyright license

Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International

10 June 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Changes in Diet and Lifestyle and Long-Term Weight Gain in Women and Men

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2014.66

21 April 2017

A human gut microbial gene catalogue established by metagenomic sequencing

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2014.66

21 April 2017

Faecalibacterium prausnitzii and human intestinal health

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2014.66

21 April 2017

Therapeutic potential of fecal microbiota transplantation

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2014.66

21 April 2017

Duodenal infusion of donor feces for recurrent Clostridium difficile

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2014.66

21 April 2017

Moving pictures of the human microbiome

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2014.66

21 April 2017

Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2014.66

21 April 2017

Should yoghurt cultures be considered probiotic?

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2014.66

21 April 2017

A metagenome-wide association study of gut microbiota in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.66

21 April 2017

Richness of human gut microbiome correlates with metabolic markers

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.66

21 April 2017

Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.66

21 April 2017

Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.66

21 April 2017

Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.66

21 April 2017

Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.66

21 April 2017

World Gastroenterology Organisation Global Guidelines: probiotics and prebiotics October 2011.

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.66

31 March 2020

Yoghurt and probiotic bacteria in dietary guidelines of the member states of the European Union.

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.66

31 March 2020

Defining a healthy human gut microbiome: current concepts, future directions, and clinical applications

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.66

31 March 2020

A meta-analysis of probiotic efficacy for gastrointestinal diseases

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.66

31 March 2020

Probiotics for treating persistent diarrhoea in children

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.66

31 March 2020

Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.66

31 March 2020

Probiotics for prevention of necrotizing enterocolitis in preterm infants

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.66

31 March 2020

Probiotics for treating acute infectious diarrhoea

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.66

31 March 2020

Probiotics, immune function, infection and inflammation: a review of the evidence from studies conducted in humans

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.66

31 March 2020

Modulation of vaccine response by concomitant probiotic administration

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.66

31 March 2020

Probiotic metabolites as epigenetic targets in the prevention of colon cancer

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.66

31 March 2020

Microbiota restoration: natural and supplemented recovery of human microbial communities

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.66

31 March 2020

Human mucosal in vivo transcriptome responses to three lactobacilli indicate how probiotics may modulate human cellular pathways

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.66

31 March 2020

Mechanisms involved in alleviation of intestinal inflammation by bifidobacterium breve soluble factors

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.66

31 March 2020

Anti-inflammatory capacity of selected lactobacilli in experimental colitis is driven by NOD2-mediated recognition of a specific peptidoglycan-derived muropeptide

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.66

31 March 2020

Scientific Opinion on the substantiation of health claims related to live yoghurt cultures and improved lactose digestion (ID 1143, 2976) pursuant to Article 13(1) of Regulation (EC) No 1924/2006

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.66

31 March 2020

Dairy consumption and risk of type 2 diabetes mellitus: a meta-analysis of cohort studies

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.66

31 March 2020

Dairy product intake in relation to glucose regulation indices and risk of type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.66

31 March 2020

The amount and type of dairy product intake and incident type 2 diabetes: results from the EPIC-InterAct Study

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.66

31 March 2020

Consumption of dairy products and associations with incident diabetes, CHD and mortality in the Whitehall II study.

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.66

31 March 2020

Yogurt consumption is associated with better diet quality and metabolic profile in American men and women

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.66

31 March 2020

Twin study indicates loss of interaction between microbiota and mucosa of patients with ulcerative colitis

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.66

31 March 2020

The gut microbiota in IBD.

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.66

31 March 2020

An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota.

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.66

31 March 2020

Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.66

31 March 2020

Antibiotic use and inflammatory bowel diseases in childhood

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.66

31 March 2020

Infant antibiotic exposures and early-life body mass

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.66

31 March 2020

Mechanisms of disease: the hygiene hypothesis revisited.

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.66

31 March 2020

What are the consequences of the disappearing human microbiota?

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.66

31 March 2020

The gut microbiota and the metabolic health of the host

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.66

31 March 2020

Understanding the effects of diet on bacterial metabolism in the large intestine

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.66

31 March 2020

A Canadian Working Group report on fecal microbial therapy: microbial ecosystems therapeutics

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.66

31 March 2020

Stool substitute transplant therapy for the eradication of Clostridium difficile infection: 'RePOOPulating' the gut.

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.66

31 March 2020

Microbial ecosystems therapeutics: a new paradigm in medicine?

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.66

31 March 2020

The GRADE approach and Bradford Hill's criteria for causation

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.66

31 March 2020

Scientific Opinion on the substantiation of health claims related to vitamin C and reduction of tiredness and fatigue (ID 139, 2622), contribution to normal psychological functions (ID 140), regeneration of the reduced form of vitamin E (ID 202), ...

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.66

31 March 2020

Vitamin C and the common cold

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.66

31 March 2020

Vitamin C and common cold incidence: a review of studies with subjects under heavy physical stress

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.66

31 March 2020

Vitamin C for preventing and treating the common cold

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.66

31 March 2020

Vitamin C for preventing and treating the common cold

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.66

31 March 2020

Vitamin D supplementation for improving bone mineral density in children

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.66

31 March 2020

Probiotics for preventing acute upper respiratory tract infections

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.66

31 March 2020

Probiotics for the prevention of Clostridium difficile-associated diarrhea: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.66

31 March 2020

A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.66

31 March 2020

Categorize probiotics to speed research

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.66

31 March 2020

Probiotics and prebiotics: prospects for public health and nutritional recommendations

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.66

31 March 2020

Rethinking "probiotics".

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.66

31 March 2020

Science and regulation. Probiotics: finding the right regulatory balance

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.66

31 March 2020

Systematic review: probiotics in the management of lower gastrointestinal symptoms in clinical practice -- an evidence-based international guide.

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.66

31 March 2020

Probiotics and clinical effects: is the number what counts?

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.66

31 March 2020

Probiotics--compensation for lactase insufficiency

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.66

31 March 2020

Health claims in Europe: probiotics and prebiotics as case examples

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2014.66

31 March 2020

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28241661&oldid=1861502746"